Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

5 Stocks With Exciting Price-to-Book Ratios

Published 09/28/2016, 06:44 AM
Updated 07/09/2023, 06:31 AM

When you're an investor, the last thing you want is to pay too much for a stock or miss a bargain price. This is where value investing comes into play.

In value investing, investors pick stocks that are cheap but fundamentally strong. Among the various ratios to identify value stocks, investors often look at price-to-earnings (P/E) and price-to-sales (P/S). While P/E is the ratio of annual earnings per share to stock price, P/S is stock price divided by sales per share.

However, the underrated price-to-book ratio (P/B ratio) can also do wonders if used properly to identify low-priced stocks with high-growth prospects. The P/B ratio is calculated as below:

P/B ratio = market capitalization / book value of equity

What is Book Value?

There are several ways by which book value can be defined. Book value is the total value that would be left over, according to the company’s balance sheet, if it goes bankrupt immediately. In other words, this is what shareholders would theoretically receive if a company liquidates all its assets after paying off all its liabilities.

It is calculated by subtracting total liabilities from total assets of a company. In most cases, this would equate to the common stockholders’ equity on the balance sheet. However, depending on the company’s balance sheet, intangible assets should also be subtracted from total assets to determine the book value.

Explaining the P/B Ratio

By comparing book value of equity to its market price, we get an idea of whether a company is under- or overpriced. However, like P/E or P/S ratio, it is always better to compare P/B ratios within industries.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

A P/B ratio less than one means that the stock is trading at less than its book value, or the stock is undervalued and therefore a good buy. Conversely, a stock with a ratio greater than one can be interpreted as being overvalued or relatively expensive.

But there is a caveat. A P/B ratio less than one can also mean that the company is earning weak or even negative return on its assets, or the assets are overstated, in which case the stock should be shunned because it may be destroying shareholder value. Conversely, the stock’s share price may be significantly high – thereby pushing the P/B ratio to more than one – in the likely case that it has become a takeover target, a good enough reason to own the stock.

Moreover, the P/B ratio isn't without its limitations. It is useful for businesses – like finance, investments, insurance and banking or manufacturing companies – with many liquid/tangible assets on the books. However, it can be misleading for firms with large R&D expenditures or high-debt companies or service companies or those with negative earnings.

In any case, the P/B is not particularly relevant as a standalone number. One should also analyze other ratios like P/E, P/S, and debt to equity before arriving at a reasonable investment decision.

Screening Parameters

Price to Book (common Equity) less than X-Industry Median: A lower P/B compared with the industry average implies that there is enough room for the stock to gain.

Price to Sales less than X-Industry Median: The P/S ratio determines how much the market values every dollar of the company’s sales/revenues — a lower ratio than the industry makes the stock attractive.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Price to Earnings using F(1) estimate less than X-Industry Median:The P/E ratio (F1) values a company based on its current share price relative to its estimated earnings per share – a lower ratio than the industry is considered better.

PEG less than 1:PEG ratio links the P/E ratio to the future growth rate of the company. PEG ratio portrays a more complete picture than the P/E ratio. A value of less than 1 indicates that the stock is undervalued and investors need to pay less for a stock that has a bright earnings growth prospect.

Current Price greater than or equal to $5: They must all be trading at a minimum of $5 or higher.

Average 20-Day Volume greater than or equal to 100,000: A substantial trading volume ensures that the stock is easily tradable.

Zacks Rank less than or equal to #2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.

Value Style Score equal to A or B: Our research shows that stocks with a Value Style Score of ‘A’ or ‘B’ when combined a Zacks Rank #1 or 2 offer the best opportunities in the value investing space.

Here are five of the seven stocks that qualified the screening:

Xerox Corporation (NYSE:XRX) is a leader in the development, manufacture, marketing, servicing and financing of document equipment across the world. The stock currently has a Zacks Rank #2 and a Value score of ‘A’. The company’s projected 3–5 year EPS growth rate is 10.0%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Korea Electric Power Corp. (NYSE:KEP) , also known as KEPCO, is an integrated electric utility engaged in the generation, transmission and distribution of electricity as well as development of electric power resources in South Korea. This Zacks Rank #1 stock has a 3–5 year EPS growth rate of 25% and a Value score of ‘A’. You can see the complete list of today’s Zacks #1 Rank stocks here.

PennyMac Financial Services, Inc. (NYSE:PFSI) is a financial services company with a projected 3–5 year EPS growth rate of 7.50%. Currently, PennyMac Financial Services carries a Zacks Rank #2 and a Value score of ‘B’.

United Therapeutics Corporation (NASDAQ:UTHR) The biotechnology company currently has a Zacks Rank #2 and a Value score of ‘B’.

Magna International Inc. (NYSE:MGA) is a leading manufacturer and supplier of automotive components. The company carries a Zacks Rank #2 and a Value score of ‘A’. Its projected 3–5 year EPS growth rate is 11.74%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your trial to the Research Wizard today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Zacks Restaurant Recommendations: Inaddition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



KOREA ELEC PWR (KEP): Free Stock Analysis Report

MAGNA INTL CL A (MGA): Free Stock Analysis Report

PENNYMAC FIN SV (PFSI): Free Stock Analysis Report

UTD THERAPEUTIC (UTHR): Free Stock Analysis Report

XEROX CORP (XRX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.